Related Experiment Video

Updated: Dec 12, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.6K

Progress in systemic therapy for triple-negative breast cancer

Hongnan Mo1, Binghe Xu2

  • 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Frontiers of Medicine
|August 14, 2020
PubMed

Insights

Triple-negative breast cancer (TNBC) is aggressive and genetically diverse. Advances in genetic analysis offer new therapeutic targets, but selecting the right patients for treatment remains challenging.

Area of Science:

  • Oncology
  • Genetics
  • Cancer Research

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype.
  • TNBC is characterized by a heterogeneous genetic profile.
  • Chemotherapy is effective in only a subset of TNBC patients, with drug resistance being a significant issue.

Purpose of the Study:

  • To review recent advances in the genetic analysis of TNBC.
  • To highlight novel therapeutic targets and precision medicine approaches for TNBC.
  • To discuss the challenges in patient selection for TNBC treatment strategies.

Main Methods:

  • Review of genetic analyses in TNBC.
  • Evaluation of current and emerging treatment strategies.
  • Analysis of clinical trial data for TNBC therapies.

Main Results:

  • Significant progress in understanding TNBC genetics.
  • Identification of novel therapeutic targets.
  • Development of advanced treatment strategies including immunotherapy and targeted drugs.

Conclusions:

  • Genetic insights have improved TNBC treatment strategies.
  • New approaches like immune checkpoint inhibitors and targeted drugs show promise.
  • Effective patient selection remains a critical challenge in clinical practice.
Keywords:
immunotherapytargeted therapytriple-negative breast cancer

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K